| http://www.w3.org/ns/prov#value | - Both empagliflozin groups also demonstrated clinically relevant reductions from baseline values in body weight and blood pressure.1 When used as monotherapy, most adults did not experience side effects such as weight gain, low blood sugar and gastrointestinal issues.2 Common side effects experienced with empagliflozin were genital infection, urinary tract infection and increased urination.
|
